Topic
vision-loss
1 stories related to this topic, newest first.
Wiredscience19 hrs ago
Life Biosciences Begins Human Trial of Cellular Rejuvenation Drug for Optic Nerve Conditions
A Boston-based company has started dosing adults in the first human study of ER-100, a therapy designed to restore function in optic-nerve cells damaged by glaucoma or NAION. The trial will track safety and side effects in roughly 18 participants over the next year.